Stock Market Watch

MEDTOX Scientific – Earnings worse than the estimates

by ·



MEDTOX Scientific, Inc. (NASDAQ:MTOX). Last Market Price: 13, Change: -0.74, % Change: (-5.39%). Shares trade in the range of 12.98 – 13.70 dollars. It has a market capitalization of 115.93M dollars, making it a Small Cap Stock and has 8.92M outstanding shares. The company has a beta of 1.06, indicating, the stock to be more volatile than the market. As per the most recent quarterly report, the net income per share (EPS) is 0.46; P/E of 28.49. It operates in Healthcare sector and belongs to Healthcare Facilities industry. Percentage shares held by institutional investors is 60%. The company has a 52 week high of $ 19.21 and a 52 week low of $ 10.93. Average volumes of shares traded daily are 23,730. Volume traded in the last session was at 7,559, 0.32 times the average volume.

  • Reports Q3 (Sep)
    • EPS $0.15 worse than the estimates
    • Revenues rose 7.0% year on year to $27.6 million

For Q2 (Jun ’11), It had a Net profit margin of 5.03%, an Operating margin of 7.78%. Other Key stats and ratios are : Return on average assets of 7.41%, Return on average equity of 10.37%. The organization has an employee strength of 633

Consensus Recommendation is a Buy.


Estimate for sales for the Year Ending Dec-11 show a mean of 110.25 million dollars, an estimate high of 111.00 million dollars and an estimate low of 109.50 million dollars. A year ago the figures stood at 107.50 million dollars.

Estimate for sales for the Year Ending Dec-12 show a mean of 124.30 million dollars, an estimate high of 128.10 million dollars and an estimate low of 120.50 million dollars. A year ago the figures stood at 117.18 million dollars.

Estimate for EPS for the Year Ending Dec-11 show a mean of 0.57 dollars, an estimate high of 0.60 dollars and an estimate low of 0.55 dollars. A year ago the figures stood at 0.69 dollars.

Estimate for EPS for the Year Ending Dec-12 show a mean of 0.81 dollars, an estimate high of 0.88 dollars and an estimate low of 0.76 dollars.

Sales for Quarter Ending Jun-11 was estimated at 27.97 million dollars, however the actual sales figure stood at 27.92 million dollars, 0.05 million dollars less than estimates.

Sales for Quarter Ending Mar-11 was estimated at 24.50 million dollars, however the actual sales figure stood at 25.74 million dollars, 1.24 million dollars more than estimates.

edliston
Post Written By: Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing in his yacht.


Tags:

Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing.

You may also like...